Navigation Links
Eutropics Pharmaceuticals signs $1.5M NCI/SBIR contract to develop companion diagnostic for guiding Multiple Myeloma treatments
Date:9/20/2012

Eutropics to put a validated test in the hands of people who will benefit from it," said Michael Cardone, Chief Executive Officer at Eutropics.

Collaborations between Eutropics and M.D. Anderson Cancer Center, the University of Massachusetts Medical School, The Mayo Clinic, TGen Corporation, the DFCI, and several pharmaceutical and biotechnology partners are currently underway to support the rapid clinical development of this technology. Funds from this contract will support validation studies leading to commercialization.  Eutropics will develop strategic alliances with pharmaceutical and diagnostic companies to distribute the test.

About BH3 profiling   
In the area of cancer treatment, understanding, detecting, and controlling mitochondrial function is a critical area of focus. Mitochondria represent a critical node for understanding how to selectively kill cancer cells while preserving non-cancer cells. BH3 profiling is used to determine if the mitochondria in a cancer cell are preset to commit a cell to death in response to upstream signaling.

This allows predicting responses to therapies that either initiate signals upstream of the mitochondria or directly target the apoptosis regulating proteins at the mitochondrial surface.  The BH3 profiling assay has proven to be highly effective at identifying when certain apoptosis inducing therapies will or will not be effective in cancer patients.

About Eutropics Pharmaceuticals   
Eutropics Pharmaceuticals is dedicated to becoming a leader in personalized cancer therapy. The company is employing proprietary BH3-profiling biomarker technology to replace empirical treatment paradigms with more targeted therapy. The biomarker provides a unique understanding of cancer cells that is important in the pre-clinical development of experimental drugs and will be important in the later stages of their development, including the developm
'/>"/>

SOURCE Eutropics Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Eutropics Pharmaceuticals awarded NCI contract to develop companion diagnostic for guiding AML treatments
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
9. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
10. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  CytRx Corporation (Nasdaq: ... specializing in oncology, today announced that David J. ... BioCentury,s 2014 NewsMakers in the Biotech Industry Conference on Friday, ... The conference will take place at the Millennium Broadway ... A live and archived webcast of the ...
(Date:9/19/2014)... -- Reductions in kidney failure obtained during ... with diabetes type 2 "Intensive treatment is ... kidneys." Australian researchers have discovered that intensive ... to persistent reductions in kidney failure many years after ... has found that, five and a half years after ...
(Date:9/18/2014)... September 19, 2014 ... http://www.researchandmarkets.com/research/qqjrnh/global_molecular ) has announced the addition of ... report to their offering. ... the study of chromosomes using molecular biology ... genes and chromosomes. It plays a crucial ...
Breaking Medicine Technology:CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3
... /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical Inc. (NYSE AMEX: ... "Company"), a developer, manufacturer and distributor of botanical ... China, today announced that the Company,s Badger Oil, ... Pharmaceutical Co., Ltd ("Renhuang"), has achieved sales of ...
... Alison MacNeil issued the following statements today regarding ... PBS this week: "When I vaccinated ... are not required to test the safety of vaccines ... thousands of parents with Autistic children report that, like ...
Cached Medicine Technology:China Botanic Pharmaceutical Provides Update on Badger Oil Sales 2China Botanic Pharmaceutical Provides Update on Badger Oil Sales 3Daughter of Journalist Robert MacNeil States that Son Regressed Into Autism After Vaccines 2
(Date:9/19/2014)... Red Bank, NJ (PRWEB) September 19, 2014 ... Jersey’s largest not-for-profit provider of home health care, hospice ... join Deutsche Bank to ring the Opening Bell yesterday ... 1912 by a New Jersey philanthropist and social entrepreneur ... other diseases, VNA Health Group has always worked to ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Boston Scientific ... mesh lawsuit ( http://www.transvaginalmeshlawsuithelp.com/ ) that is scheduled ... month, Bernstein Liebhard LLP reports. According to ... Court, the company asserts that claims involving its Solyx ... Practice and Remedies Code, a section of which shields ...
(Date:9/19/2014)... Sept. 19, 2014 (HealthDay News) -- Your brain structure could ... a new study suggests. Researchers at Yale University found ... known as the parietal cortex may be more likely to ... this area. , , The study, funded by the U.S. ... men and women living in the Northeast. The researchers sought ...
(Date:9/19/2014)... News) -- Although there is mounting evidence that ... and older adults in the United States don,t ... new research. Less than one-quarter of adults ... the Department of Health and Human Services, the ... promoting health and fitness and staying independent, researchers ...
(Date:9/19/2014)... HealthDay Reporter THURSDAY, ... by stress and family conflicts before surgery may face ... new study suggests. Investigators found that patients with ... three times greater risk for complications compared to those ... "We,ve long known that patient quality of life is ...
Breaking Medicine News(10 mins):Health News:NJ Largest Home Healthcare Not-for-Profit Joins Deutsche Bank to Ring NYSE Opening Bell 2Health News:NJ Largest Home Healthcare Not-for-Profit Joins Deutsche Bank to Ring NYSE Opening Bell 3Health News:Transvaginal Mesh Lawsuit Defendant Moves For Summary Judgment in Case Scheduled for Upcoming Texas Trial, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit Defendant Moves For Summary Judgment in Case Scheduled for Upcoming Texas Trial, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit Defendant Moves For Summary Judgment in Case Scheduled for Upcoming Texas Trial, Bernstein Liebhard LLP Reports 4Health News:Brain Structure Might Help Predict Risky Behavior 2Health News:Adults Over 45 Not Meeting U.S. Muscle Strengthening Guidelines, Study Says 2Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 2Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 3
... that food rich in carbohydrates was very effective in maintaining ... are to be presented at the Australian //Institute of Food ... study was conducted by the University of Melbourne research dietician ... obese people for a period of 12 weeks. ...
... 2 diabetes over a period of 22 years have revealed ... This has helped to highlight the need ... Dr. Mohsen Janghorbani from Isfahan University of Medical Sciences in ... a consequence of diabetes mellitus. However, this study, as well ...
... research has revealed that men and women often respond differently ... gene behavior in the organs of males and females//. ... humans, have been used as the subjects of the study ... tissue. The results of the research have been published in ...
... treating patients with mouth and throat cancer with ‘Manuka honey’, ... at the Manchester cancer hospital explained that the honey is ... Hospital in Didsbury, Manchester, are planning to use it on ... They hope to try and reduce the patient’s chances of ...
... Dr. P. Venugopal won a reprieve on Friday when ... Institute's Governing Body recommending his sacking.// ,'The decision ... Venugopal's services, is stayed and the government is restrained ... Kumar said in his order. ,He issued ...
... to introduce new legislation to regulate doctors, due to be ... seeking Government approval in order to publish heads of bill ... that a new Medical Practitioners Bill can be published later ... Act have been promised and postponed for many years, it ...
Cached Medicine News:Health News:Diabetic Women Show Increased Risks of Hip Fracture 2
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
... Indirect Ophthalmoscope Power Source provides power to ... ophthalmic instruments. The versatile wall/desk power source ... or on the side of a desk ... portable power pack provides power no matter ...
The Welch Allyn 125 BIO is designed to achieve precise binocular viewing and stereopsis easier than ever before. Its observation paths can be adjusted from 48 mm to 74 mm to handle the widest and nar...
Medicine Products: